Bradley J. Monk, MD
Bradley J. Monk, MD

Bradley J. Monk, MD

School of Medicine, Phoenix Campus

Academic Appointments


  • Obstetrics & Gynecology (Phoenix)


  • Professor

Publications and Presentations


  • Del Campo JM, Matulonis UA, Malander S, Provencher D, Mahner S, Follana P, Waters J, Berek JS,
    Woie K, Oza AM, Canzler U, Gil-Martin M, Lesoin A, Monk BJ, Lund B, Gilbert L, Wenham RM,
    Benigno B, Arora S, Hazard SJ, Mirza MR. Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial., Journal of Clinical Oncology, 2019
  • Arend RC, Toboni MD, Montgomery AM, Burger RA, Olawaiye AB, Monk BJ, Herzog TJ. Systemic treatment of metastatic/recurrent uterine leiomyosarcoma: A changing paradigm. , The Oncologist, 2018
  • Barnes D, Rivera R, Gibson S, Craig C, Cragun J, Monk B, Chase D. The utility of patient reported data in a gynecologic oncology clinic., Gynecologic Oncology Research and Practice, Volume 5, Issue 4, 2018
  • Chan JK, Brady W, Monk BJ, Brown J, Shahin MS, Rose PG, Kim JH, Secord AA, Walker JL, Gershenson DM. A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)., Gynecologic Oncology, Volume 150, Issue 2, 247-252, 2018